Trials / Completed
CompletedNCT05009030
Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients
Observational Study on the Effectiveness and Safety of Vaccination Anti-SARS-CoV2 in Patients With Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 794 (actual)
- Sponsor
- Fundación GECP · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational and multicenter retrospective study of data collection in hospital centers throughout the Spanish geography. This study aims to be nationwide in order to study general common variables of the patients, as well as the correlation with the cancer treatments received.
Detailed description
Observational and multicenter retrospective study of data collection in hospital centers throughout the Spanish geography. This study aims to be nationwide in order to study general common variables of the patients, as well as the correlation with the cancer treatments received. Disease and study population Patients with lung cancer of any histology and stage who receive an anti-COVID-19 vaccine approved by the health authorities. Patients would be eligible whether they have suffered from SARS-CoV2 infection or have not had COVID19. The study will be extended to all the centers of the Spanish Lung Cancer Group, more than 170 centers and 500 professionals, and it is expected that around 500 cases will be collected. The main objective of the study is to collect the safety and efficacy of the vaccine against SARS-CoV-2 in cancer patients, as well as its potential interactions with antineoplastic therapies. The data collection will take place throughout the year 2021
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | COVID-19 vaccine | Lung cancer patients will receive an anti-COVID19 vaccine approved by the European Medicines Agency according to the guidelines approved by the regulatory authorities |
Timeline
- Start date
- 2021-05-06
- Primary completion
- 2022-03-28
- Completion
- 2022-03-28
- First posted
- 2021-08-17
- Last updated
- 2022-07-29
Locations
51 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT05009030. Inclusion in this directory is not an endorsement.